Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease.
暂无分享,去创建一个
C. Held | C. Cannon | H. White | A. Budaj | J. Wittes | L. Wallentin | R. Harrington | P. Steg | R. Stewart | S. Krug‐Gourley | Trupti M Trivedi | E. Tarka | David Watson